Hanaa Nafady-Hego

12PUBLICATIONS
19CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical bacteriologyTeacher education and professional development of educatorsPredictive and prognostic markersClinical social work practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 03, 2026
Immunophenotypic Profiling of Lymphocyte Subsets in Children and Adolescents With Acute Lymphoblastic Leukaemia: Immune Dysregulation Before and After Remission.

|May 23, 2024
Spectrum of infection and outcomes in individuals with Candida auris infection in Qatar.

Jameela A Al Ajmi, Aimon B Malik, Hanaa Nafady-Hego

|Oct 04, 2023
SARS-CoV-2 infection in 3,241 School working staffs: Impact of SARS CoV-2 variants of concern [Wild, B.1.1.7 and Omicron].

Moza Alishaq, Jameela Ali Al Ajmi, Mohammed Shaheen

|Mar 29, 2023
Peripheral Mononuclear Cells Surface Markers Evaluation in Different Stages of Hepatocellular Carcinoma; in a Trial for Early and Accurate Diagnosis in Patients with Post-Hepatitis Liver Cirrhosis and Unremarkable Raised AFP.

Heba Ahmed Osman, Hanaa Nafady-Hego, Khalid Ali Nasif

|Jul 29, 2022
Seroprevalence of SARS-CoV-2 Infection Among Working Women and Impact of Workplace Restrictions.

Moza Alishaq, Hanaa Nafady-Hego, Andrew Jeremijenko

|Apr 11, 2022
Corrigendum: Higher proportion of non-classical and intermediate monocytes in newly diagnosed multiple myeloma patients in Egypt: A possible prognostic marker.

Asmaa M Zahran, Hanaa Nafady-Hego, Sawsan M Moeen

Pageof 2

Frequent Collaborators

3 joint publications

Adeel Ajwad Butt

2 joint publications

Asmaa M Zahran

2 joint publications

Sawsan M Moeen

2 joint publications

Hanan A Eltyb